CBT-I — the first-line insomnia treatment most people have never heard of

The official first-line treatment for chronic insomnia is not a pill. It is a behavioral protocol most patients are never offered.

CBT-I sounds like a softer version of therapy. In practice, it is closer to physical rehabilitation for the sleep system: structured, inconvenient, sometimes unpleasant, and unusually durable when it works.

I. The first-line treatment that rarely reaches patients

Ask a room of chronic insomniacs what they have tried and the list arrives quickly: melatonin, magnesium, antihistamines, zolpidem, cannabis, white noise, breathing apps, blue-light glasses, chamomile, blackout curtains. Ask how many were offered cognitive behavioral therapy for insomnia — CBT-I — as the first treatment, and the room usually gets quiet.

That is the strange part. The American Academy of Sleep Medicine gives multicomponent CBT-I a strong recommendation for chronic insomnia disorder. The American College of Physicians recommends CBT-I as the initial treatment for all adults with chronic insomnia disorder. The European Sleep Research Society guideline says the same. VA/DoD guidance also recommends offering CBT-I for chronic insomnia. The direction across guidelines is not subtle: for chronic insomnia, start with CBT-I when it is available.

Yet public awareness runs in the opposite direction. Sleeping pills are familiar. Sleep hygiene is familiar. CBT-I is what many people discover after years of failed experiments, if they discover it at all.

II. What CBT-I actually is

CBT-I is not one technique. It is a package of behavioral and cognitive components, usually delivered over four to eight sessions, built around a sleep diary and a changing prescription for when to be in bed. The exact protocol varies, but the core usually contains five pieces.

Sleep restriction. The most powerful and most misunderstood component. A patient records sleep for roughly a week. If the diary shows six hours of actual sleep, the protocol may initially allow only about six hours in bed, anchored to a fixed wake time. No going to bed early to chase sleep. No compensatory naps. Once sleep efficiency improves, time in bed is gradually expanded. Spielman, Saskin, and Thorpy's 1987 Sleep paper described this counterintuitive treatment: insomnia is often perpetuated by too much time spent awake in bed, so the first step is to compress the window until sleep pressure has somewhere to go.

Stimulus control. The bed is reserved for sleep and sex. Go to bed only when sleepy. If wakefulness takes over, leave the bed, sit somewhere dim, do something boring, and return only when sleepy again. Bootzin's 1972 stimulus-control work treated the bed as a conditioned cue. If the brain has learned "bed = awake, anxious, monitoring," the protocol teaches the opposite association.

Cognitive restructuring. This does not mean cheerful affirmations. It means challenging the catastrophic layer that insomnia adds on top of poor sleep: If I don't sleep tonight, tomorrow is ruined. I will never recover. I can only sleep with medication. The goal is not to pretend insomnia is harmless. The goal is to remove the extra threat signal that makes wakefulness self-escalating.

Sleep hygiene. Caffeine timing, alcohol, room temperature, light exposure, screens, and regular wake time still matter. The mistake is treating hygiene as the whole treatment. In CBT-I, hygiene is the smallest lever, not the machine.

Relaxation training. Progressive muscle relaxation, breathing, imagery, and similar methods can help when physical arousal is a major feature. They are adjuncts. For chronic insomnia, relaxation without sleep restriction or stimulus control often becomes one more thing to perform while lying awake.

III. The mechanism: remove what keeps insomnia alive

Chronic insomnia often outlives the event that started it. A divorce, illness, job crisis, new baby, or period of grief may trigger the first sleepless weeks. But after several months, the original precipitating event may no longer be the main engine. The engine has become the coping system built around insomnia.

Going to bed early feels logical because last night was terrible. Staying in bed for nine hours feels logical because maybe sleep will arrive eventually. Napping feels logical because the body is exhausted. Checking the clock feels logical because tomorrow's functioning seems at stake. Each behavior makes sense locally. Together they teach the brain that bed is a place of effort, monitoring, and threat.

CBT-I does not try to relitigate the original trigger. It targets the perpetuating loop. Sleep restriction rebuilds sleep pressure. Stimulus control rebuilds the bed-sleep association. Cognitive work reduces performance anxiety. The protocol is less about forcing sleep than removing the learned conditions that keep wakefulness profitable.

The evidence is not trivial. Trauer and colleagues' 2015 Annals of Internal Medicine meta-analysis of 20 randomized trials found that CBT-I improved key diary outcomes, including sleep onset latency and wake after sleep onset. Its advantage over medication is not that it works faster. It usually does not. The advantage is that it changes the system that produces sleep, so benefits can persist after active treatment ends.

IV. Why almost nobody knows about it

The puzzle is not scientific. It is institutional.

First, there is no marketing machine for behavioral sleep medicine. A pill has a manufacturer, sales reps, samples, ads, pharmacy placement, and a clean transactional story. CBT-I has protocols, therapists, diaries, and homework. There is no Pfizer of sleep restriction knocking on primary-care doors.

Second, the provider supply is thin. CBT-I is a specialized behavioral treatment. Many primary-care clinicians know insomnia guidelines in principle but have limited places to refer in practice. Even where trained behavioral sleep clinicians exist, waitlists, geography, and cost narrow access.

Third, reimbursement points the wrong way. A short prescription is easier to fit into a visit, easier to bill, and easier for a patient in distress to accept. A four-to-eight-week behavioral protocol asks for education, follow-up, adherence, and discomfort before payoff. The incentive gradient favors the faster-looking option, even when guidelines do not.

Fourth, the patient arrives in the wrong time horizon. Chronic insomnia is miserable tonight. CBT-I says the first week or two may feel worse, especially during sleep restriction. That is a hard sell to someone who has already been awake at 3 AM for months. Without careful explanation, CBT-I sounds like punishment.

Fifth, medical training still underweights behavioral sleep treatment. Many clinicians receive more exposure to pharmacology than to stimulus control, sleep diaries, or titrating time-in-bed prescriptions. The default script becomes sleep hygiene first, medication second, referral if things get complicated. CBT-I should sit near the front; in many systems, it sits behind the curtain.

V. The digital turn

The access problem is why digital CBT-I matters. It is not because software is automatically better than a trained clinician. It is because the clinician bottleneck is real, and parts of CBT-I are structured enough to be delivered programmatically: sleep diaries, sleep-window calculations, education, reminders, and weekly adjustments.

The 2025 npj Digital Medicine meta-analysis by Hwang, Lee, Woo and colleagues reviewed 29 randomized controlled trials of fully automated digital CBT-I, covering 9,475 participants. The result was not that every app works. It was narrower and more important: when a digital program actually contains CBT-I components and runs long enough to matter, the effect on insomnia severity is clinically meaningful.

That is why access now looks different than it did twenty years ago. In the UK, NICE recommends Sleepio for treating insomnia and insomnia symptoms. In the U.S., Somryst became an FDA-authorized prescription digital therapeutic for chronic insomnia in 2020, though commercial access has shifted over time. The VA's CBT-i Coach is free and public, but the VA itself frames it mainly as a companion to care, not a full replacement for therapy.

Digital CBT-I is best understood as a bridge: more scalable than specialist therapy, more evidence-based than generic sleep tips, and still not a substitute for medical evaluation when red flags are present.

VI. What CBT-I is not

It is not sleep hygiene. Sleep hygiene may be included, but if a program only tells you to avoid caffeine, keep the room cool, and stop scrolling, it is not really CBT-I.

It is not magic. A commonly cited clinical range is that roughly 70-80% of primary-insomnia patients improve with cognitive-behavioral interventions, which also means a meaningful minority do not. Some people need modified protocols, treatment for comorbid anxiety or depression, medication support, or a different diagnosis entirely.

It is not a treatment for sleep apnea. If insomnia symptoms coexist with snoring, witnessed breathing pauses, morning headaches, marked daytime sleepiness, or cardiometabolic risk, a sleep study may matter more than another behavioral workbook. CBT-I cannot reopen an airway.

It is not a cure for circadian rhythm disorder. Delayed sleep-wake phase disorder is a timing problem. It may need morning light, evening dimming, carefully timed melatonin, and phase-shifting strategy. Treating it as ordinary insomnia can make patients feel blamed for a clock problem.

It is not quick. CBT-I usually takes weeks. The first phase can be harder than the baseline, especially when sleep restriction is applied aggressively. A competent protocol should explain this up front rather than sell CBT-I as a gentle sleep tip.

VII. Where to actually get it

The cleanest route is a clinician trained in behavioral sleep medicine. The Society of Behavioral Sleep Medicine maintains a provider directory, and some sleep clinics, academic medical centers, VA/DoD settings, and behavioral health practices offer CBT-I directly.

If a specialist is unavailable, evidence-based digital programs are the next place to look. Sleepio is the best-known UK option through NICE guidance. CBT-i Coach is free and useful for sleep diaries, education, and therapist-supported care. Insomnia Coach, also from the VA ecosystem, is more explicitly self-guided. Prescription digital therapeutics such as Somryst showed where the field is going, even as access and business models continue to change.

Books can help when the insomnia is not severe or when someone is waiting for care. Two serious options are Quiet Your Mind & Get to Sleep by Colleen Carney and Rachel Manber, and Overcoming Insomnia by Jack Edinger and Colleen Carney. The key is to treat them as protocols, not bedtime reading. CBT-I is not information; it is a schedule, a diary, and a set of rules applied long enough for the brain to relearn the bed.

The real scandal is not that CBT-I is obscure. It is that the most evidence-backed treatment for chronic insomnia asks for time, training, and follow-up in a system optimized for quick prescriptions. Chronic insomnia is maintained by loops. So is its under-treatment.